Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
Langerhans cell histiocytosis (LCH) is a disease caused by clonal expansion of CD1a+/CD207+ cells and is characterized by organ involvement and dysfunction. Treatment of LCH in children is risk-adapted, and multisystem LCH requires systemic therapy. Although systemic treatments such as chemotherapy...
Saved in:
Main Authors: | Guangqiang Meng, Saran Feng, Yan Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1345855/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Langerhans cell histiocytosis in children: the value of ultrasound in diagnosis and follow-up
by: Jinjin Yang, et al.
Published: (2025-01-01) -
Clinical Characteristics and Prognostic Factors Affecting Clinical Outcomes in Cytomegalovirus Retinitis Following Allogeneic Hematopoietic Stem Cell Transplantation
by: Qiaozhu Zeng, et al.
Published: (2025-01-01) -
Case report: Gastric langerhans cell histiocytosis with BRAF deletion mutation in a child that was misdiagnosed as lymphoma
by: Zhi Wan, et al.
Published: (2025-01-01) -
Adult Spinal Langerhans Cell Histiocytosis with Conservative Treatment: A Case Report
by: Shinnosuke Kitazawa, et al.
Published: (2025-01-01) -
Beyond BRAFV600E: Investigating the Clinical and Genetic Spectrum of Langerhans Cell Histiocytosis in Children
by: Xue Tang, et al.
Published: (2024-12-01)